Market Research

Europe Pharma 4.0 Market Size, Share & Trends Analysis Report By Type (Software and Services), By Application, By End Use, By Technology (AI & ML, Big Data Analytics, IoT, Blockchain Technology, and Other Technology), By Country and Growth Forecast, 2024

Best Price Guarantee Length Publisher Published Date SKU
from $1,500 144 Pages Knowledge Based Value (KBV) Research September, 2024 KBV19169942
Best Price Guarantee
Price from $1,500
Length 144 Pages
Publisher Knowledge Based Value (KBV) Research
Published Date September, 2024
SKU KBV19169942

Europe Pharma 4.0 Market Size, Share & Trends Analysis Report By Type (Software and Services), By Application, By End Use, By Technology (AI & ML, Big Data Analytics, IoT, Blockchain Technology, and Other Technology), By Country and Growth Forecast, 2024 - 2031


The Europe Pharma 4.0 Market would witness market growth of 18.3% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Pharma 4.0 Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $2,406.6 million by 2031. The UK market is exhibiting a CAGR of 17.3% during (2024 - 2031). Additionally, The France market would experience a CAGR of 19.5% during (2024 - 2031).

Data analytics also plays a central role in this 4.0. The pharmaceutical industry generates an immense volume of data during the various stages of drug development, including research, clinical trials, production, and distribution. With big data analytics, companies can derive actionable insights from these datasets, enabling more informed decisions and process optimization.

Automation and robotics are also transforming pharmaceutical production under this 4.0. Automated systems can perform ingredient mixing, tablet pressing, and packaging more precisely and quickly than human workers. This enhances productivity and mitigates the likelihood of contamination and errors. Collaborative robots, or "cobots," are being increasingly adopted in pharmaceutical facilities to work alongside human operators, handling repetitive tasks and freeing up workers for more complex roles.

The European Union (EU) has recognized the transformative potential of this 4.0 and is actively promoting its growth through region-wide initiatives. The "Horizon Europe" program, which has allocated €93.5 billion for research and innovation from 2021 to 2027, includes substantial funding for digital health and pharmaceutical technologies. This program aims to enhance collaboration between member states, fostering innovation in AI, IoT, and data analytics within the pharmaceutical sector. Hence, this combination of national initiatives and EU-wide support reflects a growing demand for Pharma 4.0 technologies across Europe.

Based on Type, the market is segmented into Software and Services. Based on Application, the market is segmented into Drug Discovery & Development, Manufacturing, Supply Chain Management, and Other Application. Based on End Use, the market is segmented into Pharma & Biotech companies, CRO & CDMO, and Healthcare Providers. Based on Technology, the market is segmented into AI & ML, Big Data Analytics, IoT, Blockchain Technology, and Other Technology. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled
  • Amazon Web Services, Inc.
  • SAP SE
  • Oracle Corporation
  • Microsoft Corporation
  • IBM Corporation
  • GE HealthCare Technologies, Inc.
  • Siemens Healthineers AG (Siemens AG)
  • Cisco Systems, Inc.
  • Dassault Systemes SE
  • UnitedHealth Group, Inc. (Optum, Inc.)
Europe Pharma 4.0 Market Report Segmentation

By Type
  • Software
  • Services
By Application
  • Drug Discovery & Development
  • Manufacturing
  • Supply Chain Management
  • Other Application
By End Use
  • Pharma & Biotech companies
  • CRO & CDMO
  • Healthcare Providers
By Technology
  • AI & ML
  • Big Data Analytics
  • IoT
  • Blockchain Technology
  • Other Technology
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Pharma 4.0 Market, by Type
1.4.2 Europe Pharma 4.0 Market, by Application
1.4.3 Europe Pharma 4.0 Market, by End Use
1.4.4 Europe Pharma 4.0 Market, by Technology
1.4.5 Europe Pharma 4.0 Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2023, May – 2024, Sep) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Europe Pharma 4.0 Market by Type
5.1 Europe Software Market by Country
5.2 Europe Services Market by Country
Chapter 6. Europe Pharma 4.0 Market by Application
6.1 Europe Drug Discovery & Development Market by Country
6.2 Europe Manufacturing Market by Country
6.3 Europe Supply Chain Management Market by Country
6.4 Europe Other Application Market by Country
Chapter 7. Europe Pharma 4.0 Market by End Use
7.1 Europe Pharma & Biotech companies Market by Country
7.2 Europe CRO & CDMO Market by Country
7.3 Europe Healthcare Providers Market by Country
Chapter 8. Europe Pharma 4.0 Market by Technology
8.1 Europe AI & ML Market by Country
8.2 Europe Big Data Analytics Market by Country
8.3 Europe IoT Market by Country
8.4 Europe Blockchain Technology Market by Country
8.5 Europe Other Technology Market by Country
Chapter 9. Europe Pharma 4.0 Market by Country
9.1 Germany Pharma 4.0 Market
9.1.1 Germany Pharma 4.0 Market by Type
9.1.2 Germany Pharma 4.0 Market by Application
9.1.3 Germany Pharma 4.0 Market by End Use
9.1.4 Germany Pharma 4.0 Market by Technology
9.2 UK Pharma 4.0 Market
9.2.1 UK Pharma 4.0 Market by Type
9.2.2 UK Pharma 4.0 Market by Application
9.2.3 UK Pharma 4.0 Market by End Use
9.2.4 UK Pharma 4.0 Market by Technology
9.3 France Pharma 4.0 Market
9.3.1 France Pharma 4.0 Market by Type
9.3.2 France Pharma 4.0 Market by Application
9.3.3 France Pharma 4.0 Market by End Use
9.3.4 France Pharma 4.0 Market by Technology
9.4 Russia Pharma 4.0 Market
9.4.1 Russia Pharma 4.0 Market by Type
9.4.2 Russia Pharma 4.0 Market by Application
9.4.3 Russia Pharma 4.0 Market by End Use
9.4.4 Russia Pharma 4.0 Market by Technology
9.5 Spain Pharma 4.0 Market
9.5.1 Spain Pharma 4.0 Market by Type
9.5.2 Spain Pharma 4.0 Market by Application
9.5.3 Spain Pharma 4.0 Market by End Use
9.5.4 Spain Pharma 4.0 Market by Technology
9.6 Italy Pharma 4.0 Market
9.6.1 Italy Pharma 4.0 Market by Type
9.6.2 Italy Pharma 4.0 Market by Application
9.6.3 Italy Pharma 4.0 Market by End Use
9.6.4 Italy Pharma 4.0 Market by Technology
9.7 Rest of Europe Pharma 4.0 Market
9.7.1 Rest of Europe Pharma 4.0 Market by Type
9.7.2 Rest of Europe Pharma 4.0 Market by Application
9.7.3 Rest of Europe Pharma 4.0 Market by End Use
9.7.4 Rest of Europe Pharma 4.0 Market by Technology
Chapter 10. Company Profiles
10.1 Amazon Web Services, Inc. (Amazon.com, Inc.)
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental Analysis
10.1.4 Recent strategies and developments:
10.1.4.1 Partnerships, Collaborations, and Agreements:
10.1.5 SWOT Analysis
10.2 Oracle Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.5.2 Acquisition and Mergers:
10.2.6 SWOT Analysis
10.3 Microsoft Corporation
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 IBM Corporation
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional & Segmental Analysis
10.4.4 Research & Development Expenses
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.5.2 Acquisition and Mergers:
10.4.6 SWOT Analysis
10.5 SAP SE
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.5.5.2 Acquisition and Mergers:
10.5.6 SWOT Analysis
10.6 GE HealthCare Technologies, Inc.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expenses
10.6.5 Recent strategies and developments:
10.6.5.1 Product Launches and Product Expansions:
10.6.6 SWOT Analysis
10.7 Siemens Healthineers AG (Siemens AG)
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expense
10.7.5 Recent strategies and developments:
10.7.5.1 Partnerships, Collaborations, and Agreements:
10.7.6 SWOT Analysis
10.8 Cisco Systems, Inc.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Regional Analysis
10.8.4 Research & Development Expense
10.8.5 Recent strategies and developments:
10.8.5.1 Partnerships, Collaborations, and Agreements:
10.8.6 SWOT Analysis
10.9 Dassault Systemes SE
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent strategies and developments:
10.9.5.1 Partnerships, Collaborations, and Agreements:
10.9.6 SWOT Analysis
10.10. UnitedHealth Group, Inc. (Optum, Inc.)
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental Analysis

$1,500
$1,800
$2,520

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings